Cargando…

A stroma‐related lncRNA panel for predicting recurrence and adjuvant chemotherapy benefit in patients with early‐stage colon cancer

The heterogeneity in prognoses and chemotherapeutic responses of colon cancer patients with similar clinical features emphasized the necessity for new biomarkers that help to improve the survival prediction and tailor therapies more rationally and precisely. In the present study, we established a st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Rui, Sun, Huiying, Zheng, Siting, Zhang, Jingwen, Zeng, Dongqiang, Wu, Jianhua, Huang, Zhenhua, Rong, Xiaoxiang, Bin, Jianping, Liao, Yulin, Shi, Min, Liao, Wangjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077592/ https://www.ncbi.nlm.nih.gov/pubmed/31989761 http://dx.doi.org/10.1111/jcmm.14999

Ejemplares similares

Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I–III colon cancer
por: Zhou, Rui, et al.
Publicado: (2018)

A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I–III colon cancer
por: Zhou, Rui, et al.
Publicado: (2019)

Evaluation of stromal cell infiltration in the tumor microenvironment enable prediction of treatment sensitivity and prognosis in colon cancer
por: Zhou, Rui, et al.
Publicado: (2022)

CRIP1 cooperates with BRCA2 to drive the nuclear enrichment of RAD51 and to facilitate homologous repair upon DNA damage induced by chemotherapy
por: Sun, Huiying, et al.
Publicado: (2021)

Expression pattern of secretory‐cell‐related transcriptional signatures in colon adenocarcinomas defines tumor microenvironment characteristics and correlates with clinical outcomes
por: Zhou, Rui, et al.
Publicado: (2022)

Depression accelerates gastric cancer invasion and metastasis by inducing a neuroendocrine phenotype via the catecholamine/β(2)‐AR/MACC1 axis
por: Pan, Changqie, et al.
Publicado: (2021)

High baseline tumor burden‐associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2‐STAT3‐PD‐L1 pathway
por: Wen, Zhaowei, et al.
Publicado: (2023)

Comprehensive analyses reveal TKI-induced remodeling of the tumor immune microenvironment in EGFR/ALK-positive non-small-cell lung cancer
por: Fang, Yisheng, et al.
Publicado: (2021)

Pretreatment Lymphocyte Monocyte Ratio Predicts Long-Term Outcomes in Patients with Digestive System Tumor: A Meta-Analysis
por: Zhang, Jingwen, et al.
Publicado: (2016)

miR-577 Regulates TGF-β Induced Cancer Progression through a SDPR-Modulated Positive-Feedback Loop with ERK-NF-κB in Gastric Cancer
por: Luo, Yuhao, et al.
Publicado: (2019)

Immunosuppressive Microenvironment Revealed by Immune Cell Landscape in Pre-metastatic Liver of Colorectal Cancer
por: Zeng, Dongqiang, et al.
Publicado: (2021)

Evolution of tumor microenvironment in colorectal liver metastases under treatment stress
por: Huang, Na, et al.
Publicado: (2022)

Macrophage correlates with immunophenotype and predicts anti-PD-L1 response of urothelial cancer
por: Zeng, Dongqiang, et al.
Publicado: (2020)

LncRNA Snhg1-driven self-reinforcing regulatory network promoted cardiac regeneration and repair after myocardial infarction
por: Li, Mengsha, et al.
Publicado: (2021)

Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer
por: Zeng, Dongqiang, et al.
Publicado: (2021)

Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer
por: Zunder, Stéphanie M., et al.
Publicado: (2018)

Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer
por: Mezheyeuski, Artur, et al.
Publicado: (2019)

MACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression
por: Duan, Jiangman, et al.
Publicado: (2017)

lncRNA TINCR knockdown inhibits colon cancer cells via regulation of autophagy
por: Xu, Jianhua, et al.
Publicado: (2023)

Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy response
por: Wu, Jiani, et al.
Publicado: (2021)

The Stroma Liquid Biopsy Panel Contains a Stromal-Epithelial Gene Signature Ratio That Is Associated with the Histologic Tumor-Stroma Ratio and Predicts Survival in Colon Cancer
por: Ravensbergen, Cor J., et al.
Publicado: (2021)

Pancreatic Adverse Events Associated With Immune Checkpoint Inhibitors: A Large-Scale Pharmacovigilance Analysis
por: Zhang, Yue, et al.
Publicado: (2022)

A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma
por: Zhang, Huo, et al.
Publicado: (2019)

Construction and Validation of Pyroptosis-Related lncRNA Prediction Model for Colon Adenocarcinoma and Immune Infiltration Analysis
por: Liu, Qingsong, et al.
Publicado: (2022)

Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2
por: Wang, Lin, et al.
Publicado: (2015)

Clinical significance of accurate identification of lymph node status in distant metastatic gastric cancer
por: Zhou, Rui, et al.
Publicado: (2015)

PET/CT Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients
por: Rong, Xiaoxiang, et al.
Publicado: (2022)

Corrigendum: PET/Ct Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients
por: Rong, Xiaoxiang, et al.
Publicado: (2022)

Identification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastoma
por: Li, Yongsheng, et al.
Publicado: (2016)

Tumor Microenvironment Evaluation for Gastrointestinal Cancer in the Era of Immunotherapy and Machine Learning
por: Ye, Zilan, et al.
Publicado: (2022)

Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma
por: Gan, Binliang, et al.
Publicado: (2023)

The potential use and experimental validation of genomic instability-related lncRNA in pancreatic carcinoma
por: Xia, Xiuli, et al.
Publicado: (2023)

Case report: Two novel intergenic region-ALK fusions in non-small-cell lung cancer resistant to alectinib: A report of two cases
por: Liao, Shan, et al.
Publicado: (2022)

MACC-1 Promotes Endothelium-Dependent Angiogenesis in Gastric Cancer by Activating TWIST1/VEGF-A Signal Pathway
por: Wang, Lin, et al.
Publicado: (2016)

Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer
por: SU, YUQI, et al.
Publicado: (2015)

IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures
por: Zeng, Dongqiang, et al.
Publicado: (2021)

Flotillin-2 promotes nasopharyngeal carcinoma metastasis and is necessary for the epithelial-mesenchymal transition induced by transforming growth factor-β
por: Zhao, Liang, et al.
Publicado: (2015)

A Modified Surgical Ventricular Reconstruction in Post-infarction Mice Persistently Alleviates Heart Failure and Improves Cardiac Regeneration
por: Ma, Siyuan, et al.
Publicado: (2021)

Effect of lncRNA THOR on proliferation and migration of colon cancer cells
por: Lv, Ying, et al.
Publicado: (2019)

A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma
por: Fu, Xiaorui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rkkrnata0u0t5lnh1fk5vphou5